Thank you for your work. I am stunned and amazed to read that antibodies, even neutralizing antibodies, promote severe disease. This is certainly not what we have been told by the health bureaucrats. I look forward to more information on this subject.
Yes actually all the medical scientists and vaccinologists and the Brighton Collaboration on Vaccine Safety anticipated (and feared) that antibody dependent enhancement (ADE) of infection into macrophages could spell "big trouble". What was not anticipated was that the ADE mechanism would not provide selection pressure for the generation of variants during natural infection. It turns out the COVID-19 vaccines but not natural infection caused the emergence of the alpha and delta variants (see my post July 1, 2022 which goes through the evidence). Using a vaccine that itself selects for variants is like shooting oneself in the foot. It just prolongs the pandemic, not to mention spike protein is quite toxic.
No it was just submitted a few days back and it was an invited review. It usually takes a few months to know the status. I will let you know as soon as it is accepted or not. The substack article is just an overview of what was discovered during my research for the new vaccinology paradigm.
I feel that it would be important to understand what you are writing in this blog, but i cannot get past the first few sentences in each article because of some basic concepts i am lacking:
- what is HERV-K102?
- what is a foamy macrophage?
- how do these things fit into the innate and adaptive immune system?
- why dont other immunologists and vaccinologists write about them?
Perhaps you or another reader can point me to a student's guide to begin learning (quickly) about these things, and then it can be added to an FAQ for your page.
Alot of your questions are dealt with in the following article: 137. Laderoute MP. Clues to finding correlates of risk/protection for HIV-1 vaccines [version 2; peer review: 2 approved with reservations] F1000 Research 2018, 6:868. https://doi.org/10.12688/f1000research.11818.2.
You are not alone. Most people including doctors and scientists have never heard of them. I have written 2 large papers and submitted these which would address your issues. In the meantime go to some of the earlier substack articles to read up on what HERV-K102 is. Short answers: HERV-K102 is a protector FOAMY virus unique to humans located on chromosome 1 (1q22) that mediates a viral anti-viral response CRITICAL to protect humans against emerging or pandemic RNA viruses. A foamy macrophage is a macrophage producing HERV-K102 particles which induces foam in the cells. The HERV-K102 protector system mediates trained INNATE immunity, and is favored with optimal Vit D3 levels. Some virologists do not believe that HERV-K102 is replication competent/produces active particles despite their own evidence of isolated particles in the plasma but with DNA genomes.
Thank you for your work. I am stunned and amazed to read that antibodies, even neutralizing antibodies, promote severe disease. This is certainly not what we have been told by the health bureaucrats. I look forward to more information on this subject.
Yes actually all the medical scientists and vaccinologists and the Brighton Collaboration on Vaccine Safety anticipated (and feared) that antibody dependent enhancement (ADE) of infection into macrophages could spell "big trouble". What was not anticipated was that the ADE mechanism would not provide selection pressure for the generation of variants during natural infection. It turns out the COVID-19 vaccines but not natural infection caused the emergence of the alpha and delta variants (see my post July 1, 2022 which goes through the evidence). Using a vaccine that itself selects for variants is like shooting oneself in the foot. It just prolongs the pandemic, not to mention spike protein is quite toxic.
No it was just submitted a few days back and it was an invited review. It usually takes a few months to know the status. I will let you know as soon as it is accepted or not. The substack article is just an overview of what was discovered during my research for the new vaccinology paradigm.
I feel that it would be important to understand what you are writing in this blog, but i cannot get past the first few sentences in each article because of some basic concepts i am lacking:
- what is HERV-K102?
- what is a foamy macrophage?
- how do these things fit into the innate and adaptive immune system?
- why dont other immunologists and vaccinologists write about them?
Perhaps you or another reader can point me to a student's guide to begin learning (quickly) about these things, and then it can be added to an FAQ for your page.
Alot of your questions are dealt with in the following article: 137. Laderoute MP. Clues to finding correlates of risk/protection for HIV-1 vaccines [version 2; peer review: 2 approved with reservations] F1000 Research 2018, 6:868. https://doi.org/10.12688/f1000research.11818.2.
Go to : https://doi.org/10.12688/f1000research.11818.2
You are not alone. Most people including doctors and scientists have never heard of them. I have written 2 large papers and submitted these which would address your issues. In the meantime go to some of the earlier substack articles to read up on what HERV-K102 is. Short answers: HERV-K102 is a protector FOAMY virus unique to humans located on chromosome 1 (1q22) that mediates a viral anti-viral response CRITICAL to protect humans against emerging or pandemic RNA viruses. A foamy macrophage is a macrophage producing HERV-K102 particles which induces foam in the cells. The HERV-K102 protector system mediates trained INNATE immunity, and is favored with optimal Vit D3 levels. Some virologists do not believe that HERV-K102 is replication competent/produces active particles despite their own evidence of isolated particles in the plasma but with DNA genomes.
thanks!
Where is this lengthy review published, or where have you submitted it to, in addition to the description on this substack article?
Or is this substack article your review?